{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:59:08Z","timestamp":1762855148657,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Gedeon Richter Portugal"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jogoh.2020.101862","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T12:12:23Z","timestamp":1594210343000},"page":"101862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of symptomatic uterine fibroids with ulipristal acetate: A retrospective, multicentric and nationwide study"],"prefix":"10.1016","volume":"49","author":[{"given":"Fernanda","family":"\u00c1guas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Martinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Vilhena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2020.101862_bib0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Mechanisms of disease: uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2020.101862_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2020.101862_bib0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003211","article-title":"Health-related quality of life with ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Lukes","year":"2019","journal-title":"Obstet Gynecol"},{"year":"2018","author":"Stewart","series-title":"The comparing options for management: PAtient-centered REsults for uterine fibroids (COMPARE-UF) registry: rationale and design","key":"10.1016\/j.jogoh.2020.101862_bib0020"},{"key":"10.1016\/j.jogoh.2020.101862_bib0025","doi-asserted-by":"crossref","first-page":"492.e1","DOI":"10.1016\/j.ajog.2011.07.008","article-title":"Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends","volume":"205","author":"Wechter","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2020.101862_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101862_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101862_bib0040","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-017-0812-3","article-title":"Ulipristal acetate: a review in symptomatic uterine fibroids","volume":"77","author":"Garnock-Jones","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jogoh.2020.101862_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13697137.2018.1549216","article-title":"Fibroid management in premenopausal women","volume":"22","author":"Donnez","year":"2019","journal-title":"Climacteric"},{"key":"10.1016\/j.jogoh.2020.101862_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jogoh.2020.101862_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.03.009","article-title":"Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma","volume":"196","author":"Jacobson","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2020.101862_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/AOG.0000000000001160","article-title":"Association between patient characteristics and treatment procedure among patients with uterine leiomyomas","volume":"127","author":"Borah","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2020.101862_bib0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ijgo.12968","article-title":"Effect on surgical decisions: ulipristal acetate as key player in Belgian phase IV registration trial","volume":"147","author":"Verguts","year":"2019","journal-title":"Int J Gynecol Obstet"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720302130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720302130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:56:28Z","timestamp":1762854988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784720302130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2468784720302130"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101862","relation":{},"ISSN":["2468-7847"],"issn-type":[{"type":"print","value":"2468-7847"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of symptomatic uterine fibroids with ulipristal acetate: A retrospective, multicentric and nationwide study","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101862"}}